Table . | . | Convergent validity . | Discriminant validity . | Construct validity without either a combination of trait and method effects or a mono-method bias . |
---|---|---|---|---|
8 | Level of importance of contracting R&D with the number of IP mechanisms used | Yes | Yes | No |
9 | Level of importance of contracting R&D with the number of patents | Yes | Yes | Yes |
10 | Level of importance of providing R&D with the number of IP mechanisms used | Yes | Yes | Yes |
11 | Level of importance of providing R&D with the number of patents | Yes | Yes | Yes |
12 | Prop. of employees assigned primarily in R&D with the number of IP mechanisms used | Yes | Weak yes | Weak yes |
13 | Prop. of employees assigned primarily in R&D with the number of patents | Yes | No | Yes |
Table . | . | Convergent validity . | Discriminant validity . | Construct validity without either a combination of trait and method effects or a mono-method bias . |
---|---|---|---|---|
8 | Level of importance of contracting R&D with the number of IP mechanisms used | Yes | Yes | No |
9 | Level of importance of contracting R&D with the number of patents | Yes | Yes | Yes |
10 | Level of importance of providing R&D with the number of IP mechanisms used | Yes | Yes | Yes |
11 | Level of importance of providing R&D with the number of patents | Yes | Yes | Yes |
12 | Prop. of employees assigned primarily in R&D with the number of IP mechanisms used | Yes | Weak yes | Weak yes |
13 | Prop. of employees assigned primarily in R&D with the number of patents | Yes | No | Yes |